| Primary |
| Product Used For Unknown Indication |
29.8% |
| Hypotension |
17.0% |
| Septic Shock |
10.6% |
| Haemodynamic Instability |
6.4% |
| Cerebrovascular Spasm |
4.3% |
| Back Pain |
2.1% |
| Blood Pressure Fluctuation |
2.1% |
| Brain Oedema |
2.1% |
| Cardiac Arrest |
2.1% |
| Cardiac Failure Congestive |
2.1% |
| Dyspnoea Exertional |
2.1% |
| Headache |
2.1% |
| Hypertension |
2.1% |
| Postpartum Haemorrhage |
2.1% |
| Prophylaxis |
2.1% |
| Pyelonephritis |
2.1% |
| Radiation Skin Injury |
2.1% |
| Sedation |
2.1% |
| Shock Haemorrhagic |
2.1% |
| Traumatic Brain Injury |
2.1% |
|
| Medication Error |
20.6% |
| Wrong Drug Administered |
11.8% |
| Circumstance Or Information Capable Of Leading To Medication Error |
8.8% |
| Peripheral Ischaemia |
5.9% |
| Respiratory Failure |
5.9% |
| Tachycardia |
5.9% |
| Aspartate Aminotransferase Increased |
2.9% |
| Bradycardia |
2.9% |
| Cardiac Arrest |
2.9% |
| Contusion |
2.9% |
| Convulsion |
2.9% |
| Drug Dispensing Error |
2.9% |
| Incorrect Dose Administered |
2.9% |
| Infusion Site Oedema |
2.9% |
| Injection Site Exfoliation |
2.9% |
| Intercepted Drug Dispensing Error |
2.9% |
| Intercepted Medication Error |
2.9% |
| Maternal Drugs Affecting Foetus |
2.9% |
| Myocardial Ischaemia |
2.9% |
| Pain In Extremity |
2.9% |
|
| Secondary |
| Sedation |
23.5% |
| Product Used For Unknown Indication |
19.1% |
| Drug Use For Unknown Indication |
15.1% |
| Cardiac Disorder |
5.3% |
| Vasodilatation |
5.1% |
| Overdose |
3.8% |
| Hypotension |
3.1% |
| Blood Pressure Management |
2.9% |
| Anaesthesia |
2.5% |
| Hypertension |
2.5% |
| Cardiogenic Shock |
2.2% |
| Pain |
2.2% |
| Colon Cancer |
1.8% |
| Electrolyte Substitution Therapy |
1.8% |
| Rash |
1.8% |
| Circulatory Collapse |
1.6% |
| Analgesic Therapy |
1.5% |
| Prophylaxis |
1.5% |
| Resuscitation |
1.5% |
| Hypotonia |
1.3% |
|
| Ventricular Dysfunction |
14.5% |
| Toxic Epidermal Necrolysis |
10.1% |
| Urine Colour Abnormal |
10.1% |
| Intestinal Ischaemia |
7.2% |
| Medication Error |
7.2% |
| Hypotension |
5.8% |
| Cardiogenic Shock |
4.3% |
| Renal Failure Acute |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Arteriospasm Coronary |
2.9% |
| Cardiac Arrest |
2.9% |
| Convulsion |
2.9% |
| Decubitus Ulcer |
2.9% |
| Disseminated Intravascular Coagulation |
2.9% |
| Drug Ineffective |
2.9% |
| Hyperkalaemia |
2.9% |
| Hypertension |
2.9% |
| Hypokalaemia |
2.9% |
| Pyrexia |
2.9% |
| Rhabdomyolysis |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
65.8% |
| Drug Use For Unknown Indication |
9.4% |
| Prophylaxis |
3.6% |
| Coronary Artery Bypass |
3.1% |
| Sedation |
2.4% |
| Sepsis |
2.0% |
| Septic Shock |
1.6% |
| Pain |
1.4% |
| Ill-defined Disorder |
1.4% |
| Infection |
1.0% |
| Pneumonia |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
| Hypertension |
0.9% |
| Catheterisation Cardiac |
0.9% |
| Hypotension |
0.9% |
| Aortic Valve Replacement |
0.8% |
| Mitral Valve Replacement |
0.8% |
| Infection Prophylaxis |
0.7% |
| Premedication |
0.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.6% |
|
| Injury |
11.8% |
| Pain |
8.5% |
| Anxiety |
6.9% |
| Sepsis |
6.9% |
| Unevaluable Event |
6.5% |
| Septic Shock |
5.9% |
| Renal Failure |
5.2% |
| Thrombocytopenia |
4.9% |
| Multi-organ Failure |
4.6% |
| Anhedonia |
3.9% |
| Respiratory Failure |
3.9% |
| Vomiting |
3.9% |
| Emotional Distress |
3.6% |
| Fear |
3.6% |
| Hypotension |
3.6% |
| Renal Failure Acute |
3.6% |
| Ventricular Tachycardia |
3.6% |
| Renal Impairment |
3.3% |
| Stevens-johnson Syndrome |
3.3% |
| Death |
2.6% |
|
| Interacting |
| Pneumonia Staphylococcal |
100.0% |
|
| Platelet Count Decreased |
100.0% |
|
